Hob Biotech Group Corp.,Ltd.’s Net Profit Dropped 40.5% in First Three Quarters of 2022

Hob Biotech Group Corp.,Ltd. (江苏浩欧博生物医药股份有限公司) (688656.SH) reported a net profit of 44.5 million yuan in the first three quarters of 2022, down 40.5% year-on-year.

Meanwhile, the company posted 254.6 million yuan in revenue, up 7.9% year-on-year.

At the end of the reporting period, it had 890.3 million yuan in total assets and 105.9 million yuan in total liabilities, with a liability-to-asset ratio of 11.9%.